Changes in the seroepidemiology of hepatitis A virus infection in Catalonia (Spain) from 1989 to 1996. Implications for a new vaccination strategy;Cambios en la seroepidemiología de la infección por el virus de la hepatitis A en Cataluña en el període 1989-1996. Implicaciones para una nueva estrategia vacunal

Medicina Clinica

Volumn 112, Issue 11, 1999, Pages 406-408

  Bruguera, Miguel ^a   Salleras, Lluís ^b   Plans, Pere ^b   Vidal, Josep ^a   Navas, Encarna ^b   Domínguez, Ángela ^b   Batalla, Joan ^b   Taberner, Josep Lluís ^b   Espuñes, Jordi ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS VACCINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; HEPATITIS A; HUMAN; MIDDLE AGED; SPAIN; STATISTICAL MODEL; VACCINATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CROSS-SECTIONAL STUDIES; HEPATITIS A; HEPATITIS A VACCINES; HUMANS; LOGISTIC MODELS; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; SPAIN; VACCINATION; VIRAL HEPATITIS VACCINES;

EID: 0040294498     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Salleras L, Bruguera M, Vidal J, Taberner JL, Plans P, Jiménez de Anta MT et al. Cambio en el patrón epidemiológico de la hepatitis A en Espana. Med Clin (Barc) 1992; 99: 87-89.
2. Papaevangelou G. Epidemiological pattern of hepatitis A in Mediterranean countries. Vaccine 1992; 10 (Sup 1): 63-66.
3. Gust ID. Epidemiological pattern of hepatitis A in different parts of the world. Vaccine 1992; 10 (Supl 1): 56-58.
4. Chin KP, Lok ASF, Wong LSK, Lai GL, Wu PC. Current seroepidemiology of hepatitis A in Hong Kong. J Med Virol 1991; 34: 191-193.
5. Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL. Changing seroepidemiology of hepatitis A virus infection in Taiwan. J Med Virol 1995; 17: 297-301.
6. Ikematsu H, Kashiwagi S, Hayashi J, Hayashi J, Nomura H, Kajiyama W et al. A seroepidemiological study of hepatitis A virus infection: statistical analysis of two independent cross-sectional survey in Okinawa, Japan. Am J Epidemiol 1987; 17: 50-54.
7. Wang HY, Hn SL, Lin NY, Hong YL, Cao SZ, Wn LF. Risk factors analysis of an epidemic of hepatitis A in a factory in Shanghai. Int J Epidemiol 1990; 19: 435-438.
8. Mele A, Rastelli MG, Gill ON, Di Bisceglie D, Rosmini F, Pardelli G et al. Recurrent epidemic hepatitis A with consumption of raw shellfish probably controlled through public health measures. Am J Epidemiol 1989; 130: 540-546.
9. Social Class. Office of Population Census. Londres: OPSC, 1976.
10. Norusis NJ, SPSS Advanced Statistics. Chicago: SPSS Inc., 1988.
11. Dubois F, Thevenas C, Caces E, Vol S, Doctoriarena A, Ecault JL et al. Séroepidemiologie de l'hépatite A dans six departments du centreonest de la France en 1991. Gastroenterol Clin Biol 1992; 16: 674-679.
12. Gonzalez A, Bruguera M, Calbo F, Monge V, Dal-Re R, Costa J et al. Encuesta seroepidemiológica de prevalencia de anticuerpos antihepatitis A en la población adulta joven española. Med Clin (Barc) 1994; 103: 445-448.
13. Shapiro CN, Coleman PJ, McQuillan GM, Alter MJ, Margolis HS. Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA. Vaccine 1992; 10 (Supl 1): 19-62.
14. Koff RS. Seroepidemiology of hepatitis A in the United States. J Infect Dis 1995; 171 (Supl 1): 19-23.
15. Gay NJ, Morgan-Caper P, Wright J, Fanigton CP, Miller E. Age-specific antibody prevalence to hepatitis A in England. Epidemiol Infect 1994; 113: 113-120.
16. Iwarson S, Frosner G, Lindhom A, Norkrans G. The changed epidemiology of hepatitis A infection in Scandinavia. Scand J Infect Dis 1988; 10: 155-156.
17. Ukkonen P. Hepatitis A antibodies in Finland. Scand J Infect Dis 1979; 11: 311-312.
18. Zanetti AR, Romanò L, Tanzi E, Andreasso A, Pozzi A, Panuccio A et al. Decline in anti-HAV prevalence in the Milan area between 1958 and 1992. Eur J Epidemiol 1994; 10: 633-635.
19. Stroffonini T, Franco EM, Romano G et al. Hepatitis A virus infection in children in Sardinia Palermo. Commun Med 1989; 11: 336-341.
20. Stroffolini T, De Crescenzo L, Giammanco A, Intonazzo V, La Rosa G, Cascio A et al. Changing paterns of hepatitis A virus infection in children in Palermo, Italy. Eur J Epidemiol 1990; 6: 84-87.
21. Chiaramonte M, Moschen ME, Stroffolini et al. Changing epidemiology of hepatitis A virus (HAV) infection: a comparative seroepidemiological study (1979 vs 1989) in north-east Italy. J Gastroenterol 1991; 23: 244-346.
22. Kremastinou J, Kalapathaki V, Trichopoulos D. The changing epidemiologic pattern of hepatitis A infection in urban Greece. Am J Epidemiol 1984; 120: 703-706.
23. Lednar WN, Lemon SM, Kirkpatrick JW, Redfield RR, Fields ML, Kelley PW. Frequency of Illness associated with hepatitis A virus infection in adults. Am J Epidemiol 1985; 122: 226-231.
24. Mele A, Stroffolini T, Palumbo F, Gallo G, Ragni P, Balocchini E et al. Incidence and risk factors for hepatitis A in Italy: public health indication from a 10 years surveillance. J Hepatol 1997; 26: 743-747.
25. Steffen R. Hepatitis A in travellers: the European experience. J Infect Dis 1995; 171: 524-528.
26. Vacuna contra la hepatitis A y vacuna combinada contra la hepatitis A y B. Boletín Epidemiológico Semanal 1996; 4: 381-392.
27. Dirección General de Salut Pública, Departament de Sanitat i Seguretat Social. Déu anys de vacunació antihepatitis B a Catalunya. Butiletí Epidemiològic de Catalunya 1985; 16: 137-144.
28. Van Damme P, Kane M, Meheus A. Integration of hepatitis B vaccination into national immunisation programme. Br Med J 1997; 314: 1.033-1.037.
29. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997; 336: 1.855-1.859.
30. Domínguez A, Vidal J, Bruguera M, Salleras L. Epidemiología de las hepatitis virales. Enferm Infecc Microbiol Clin 1995; 13 (Supl 1): 50-61.
31. Navas E, Bayas JM, Bruguera M, Vidal J, Galí N, Taberner JL et al. Eficiencia de la detección prevacunal de anti-VHA en los programas de vacunación antihepatitis A. Med Clin (Barc) 1995; 105:168-171.